Company
SyntheX
Next-Gen Precision Drug Discovery
Also known as SyntheX, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- external partners
- Legal name
- SyntheX, Inc.
- synthexlabs.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
SyntheX is expanding the frontier of drug discovery with target-centric cell-based functional selection.
Funding snapshot
- Total raised
- $10.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.2M2023-12-29
Funding rounds
- Round, 2023
- $5.2M2023-12-29, SEC form D sold, 10 investors
- Round, 2017
- $4.9M2017-02-17, SEC form D sold, 5 investors
Products
- Other
- ToR FLEx
Loading relationship preview